Table 1.
Co-stimulatory molecule expression on pulmonary DC populations following allergen exposure
| Treatment | mDC |
pDC |
||
|---|---|---|---|---|
| CD80 MFI | CD80 Freq of parent | CD80 MFI | CD80 Freq of parent | |
| PBS | 208 ± 12 | 4.1 ± 0.6 | 199 ± 21 | 6.1 ± 0.4 |
| GC frass | 1,128 ± 60 | 38.5 ± 3.3 | 194 ± 41 | 6.7 ± 0.6 |
| p value | <0.001 | <0.001 | ns | ns |
| Treatment | mDC |
pDC |
||
|---|---|---|---|---|
| CD86 MFI | CD86 Freq of parent | CD86 MFI | CD86 Freq of parent | |
| PBS | 480 ± 3 | 10.6 ± 0.6 | 188 ± 29 | 7.2 ± 1.3 |
| GC frass | 1,134 ± 59 | 22.7 ± 1.1 | 361 ± 21 | 8.1 ± 0.2 |
| p value | <0.001 | <0.001 | 0.007 | ns |
Naive mice were administered a single intratracheal inhalation of PBS (40 μl) or GC frass (40 μg/40 μl) and whole lungs were isolated 24 h later. Cells were dissociated from the lungs, and stained for flow cytometry analysis. mDC (CDllc+, CDllb+, Grlneg, CD317neg) and pDC (CDllc+, CDllbneg, Grllow, CD317+) populations were analyzed for CD86 and CD80 expression. Mean fluorescent intensity (MFI) and percentage of cells expressing the co-stimulatory molecules are shown. Values are means ± SEM, n = 8 mice/group and statistical analysis was performed by ANOVA.